期刊文献+

特发性血小板减少性紫癜治疗方案的选择 被引量:2

The choice of therapy protocol for idiopathic thrombocytopenic purpura
下载PDF
导出
摘要 目的:评价特发性血小板减少性紫癜(ITP)治疗方案,选择合理的治疗模式。方法:采用回顾性病例分析,对不同治疗组治疗ITP的有效率、血小板上升速度进行比较。结果:单纯激素治疗组、激素加免疫抑制剂组、激素加丙种球蛋白组、脾切除组的有效率分别为61%、33%、71%、82%。血小板上升至正常的时间分别为9.23±4.65、14.25±5.12、5.50±1.60、2.50±1.91d。激素加丙种球蛋白组、脾切除组的有效率及血小板上升速度均优于另两组,P<0.05(组间比较t检验)。结论:激素加丙种球蛋白应作为ITP治疗首选方案,对于不能用激素维持及减量后复发的病人,应尽早做脾切除。 Objective:To evaluate the protocols of Idiopathic thrombocytopenic purpura (ITP)and choose the best treatment mode.Method Use the retrospective analysis to compare the efficiencies and ascendent rates of platelets.Results the efficiency of the pure corticosteroids treatment group is61%,the corticosteroids plus immunosuppressants group is33%,the corticosteroids plus gamma-globulin group is71%,the splenectomy group is82%.The time for platelets to rise to normal level is9.23±4.65,14.25±5.12,5.50±1.60,2.50±1.91days respectively.The corticosteroids plus immunosuppressants group and the splenectomy group see better results in both the two indexes,P<0.05(t test).Conclusion Our findings suggest that corticosteroids plus gammaglobulin may be the firstly con-siderable treatment of ITP,and the the splenectomy should be executed early for those who can not be maintained with corticos-teroids or relapse when reduce the dose(or both).
出处 《吉林医学》 CAS 2004年第10期9-10,共2页 Jilin Medical Journal
  • 相关文献

参考文献1

共引文献1

同被引文献12

  • 1曹苇,朱琬莹,汪健,徐乃元,朱麟,陈易人.脾切除治疗特发性血小板减少性紫癜202例[J].中华普通外科杂志,2004,19(6):346-348. 被引量:17
  • 2曾艳,高清平,陈友华,敖绪斌,陈伦华,王琼玉,胡文斌.特发性血小板减少性紫癜患者B淋巴细胞凋亡研究[J].临床内科杂志,2005,22(6):378-380. 被引量:5
  • 3第五届全国血栓与止血会议.关于特发性血小板减少性紫癜诊断标准备修订方案[J].中华血液学杂志,1995,16(3):331.
  • 4[7]Najean Y,Rain JD,Billotey C.The site of destruction of autologous 111-In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocy topenic purpura:a study of 578 patients with 268 splenectonies[J].Br J Hae matol,1997,97:547-550.
  • 5George J N, Woof S H, RuskobGE, et al. Idiopathic throm-bocytopenic purpura: a practice guideline developed by explicitmethods American Society of Hematology [ J]. Blood, 1996,88: 3.
  • 6Semple J W, Freedman J. Cellular immune mechanisms inchronic autoimmune thrombocytopenic purpura[J]. Autoim-munity ,1992,13: 311.
  • 7Olsson B, Andersson P 0,Jemas M, et al. T-cell-mediatedcytotoxicity toward platelets in chronic idiopathic thrombocy-topenic purpura [J]. NatMed, 2003, 9: 1123.
  • 8Giovanni E, Mario L, Monica M, et al. A possible role forlow — dose cyclosporine in refractory immune thrombocytopenicpurpura[j]. Haematologica, 2008, 93(7) : 1113.
  • 9罗璟,陈路.丙种球蛋白治疗特发性血小板减少性紫癜疗效观察[J].海南医学院学报,2010,16(2):232-233. 被引量:17
  • 10吉承玲,孙梅,顾健.小剂量CD_(20)单克隆抗体联合冰冻血浆治疗免疫性血小板减少症的护理[J].实用临床医药杂志(护理版),2010,14(10):57-57. 被引量:6

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部